Rist Michael, Kaku Machika, Coffin John M
bioRxiv. 2025 Mar 31:2025.03.31.646272. doi: 10.1101/2025.03.31.646272.
Oncogenic retroviruses are known for their pathogenesis via insertional mutagenesis, in which the presence of a provirus and its transcriptional control elements alter the expression of a nearby or surrounding host gene. There are reports of proviral integration driving oncogenesis in people with HIV and the use of HIV-derived vectors for gene therapy has raised concern about oncogenic side effects. To study this issue, we used an ex vivo human CD4+ T cell infection model developed in our laboratory to identify HIV-1 integration sites that might influence cell proliferation or survival. Combining integration site analysis and bulk RNA sequencing, we established that an upregulated signature due to proviral insertional mutagenesis was associated with persistent HIV-infected CD4+ T cells. HIV+ persistent cells also expressed a STAT3-related anti-apoptotic and cytotoxic phenotype that resembles that of HIV-associated T cell lymphomas. HIV insertional mutagenesis of and expression of its downstream targets provides a model of HIV-associated T cell lymphomas that can be used to further determine the oncogenic drivers of HIV-associated lymphomas, both AIDS- and gene therapy-associated, and, potentially, to evaluate therapeutics against these HIV-associated cancers.
The effects of HIV proviral insertional mutagenesis have been demonstrated in a handful of HIV-associated T cell lymphomas, where integration of an HIV provirus within intron 1 of , results in increased expression of the STAT3 protein. To study the effects of HIV insertional mutagenesis, we established an ex vivo culture protocol of primary human CD4+ T cells infected with a replication-incompetent HIV vector with a gfp-reporter. After infection, the HIV/GFP+ cells from all three donors declined, but, over time, 3/6 replicates from one donor populations of infected cells rebounded. The resurgent HIV/GFP+ cells contained a provirus integrated within intron 1 of , which led to increases in gene expression, activation, and upregulation of a -associated anti-apoptotic and cytotoxic phenotype. The -associated gene signature shared similarities to the HIV-associated lymphomas with similar integration sites. Additionally, in all 3 replicates, insertional mutagenesis of genes other than may have also contributed to clonal expansion of HIV/GFP+ T cells. Overall, we have demonstrated that HIV provirus insertional mutagenesis can influence T cell persistence. Our study provides a primary T cell culture model system that can be used to further study how proviral insertional mutagenesis influences HIV-associated T cell lymphomas and the safety of lentiviral vectors used in gene and cell therapies.
致癌逆转录病毒以通过插入诱变的发病机制而闻名,其中前病毒及其转录控制元件的存在会改变附近或周围宿主基因的表达。有关于前病毒整合在HIV感染者中驱动肿瘤发生的报道,并且用于基因治疗的HIV衍生载体引发了对致癌副作用的担忧。为了研究这个问题,我们使用了在我们实验室开发的体外人CD4 + T细胞感染模型来鉴定可能影响细胞增殖或存活的HIV-1整合位点。结合整合位点分析和大量RNA测序,我们确定由于前病毒插入诱变导致的上调特征与持续HIV感染的CD4 + T细胞相关。HIV + 持续细胞还表达了一种与STAT3相关的抗凋亡和细胞毒性表型,类似于HIV相关的T细胞淋巴瘤。HIV插入诱变及其下游靶标的表达提供了HIV相关T细胞淋巴瘤的模型,可用于进一步确定与HIV相关的淋巴瘤(包括与艾滋病和基因治疗相关的淋巴瘤)的致癌驱动因素,并有可能评估针对这些HIV相关癌症的治疗方法。
HIV前病毒插入诱变的影响已在少数HIV相关的T细胞淋巴瘤中得到证实,其中HIV前病毒整合在 的内含子1内,导致STAT3蛋白表达增加。为了研究HIV插入诱变的影响,我们建立了用带有gfp报告基因的无复制能力的HIV载体感染的原代人CD4 + T细胞的体外培养方案。感染后,来自所有三个供体的HIV/GFP + 细胞数量下降,但随着时间的推移,来自一个供体感染细胞群体的6个复制品中的3个出现反弹。复苏的HIV/GFP + 细胞含有整合在 的内含子1内的前病毒,这导致基因表达增加、 激活以及与 相关的抗凋亡和细胞毒性表型上调。与 相关的基因特征与具有相似整合位点的HIV相关淋巴瘤有相似之处。此外,在所有3个复制品中,除 以外的基因的插入诱变也可能促成了HIV/GFP + T细胞的克隆扩增。总体而言,我们已经证明HIV前病毒插入诱变可以影响T细胞的持久性。我们的研究提供了一个原代T细胞培养模型系统,可用于进一步研究前病毒插入诱变如何影响HIV相关的T细胞淋巴瘤以及基因和细胞治疗中使用的慢病毒载体的安全性。